Brain amyloid - A physicochemical perspective

Brain Pathology

Volumn 6, Issue 2, 1996, Pages 147-162

  Maggio, John E ^a   Mantyh, Patrick W ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; BIOCHEMISTRY; HUMAN; REVIEW;

EID: 0029895147     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00797.x     Document Type: Review

References (100)

1. Allen CJ, Ghilardi JR, Stimson ER, Vinters HV, Dysken MW, Maggio JE, Mantyh PW (1992) Specificity, sensitivity and ability to quantify amyloid deposits in Alzheimer's disease brain using either radioiodinated βA4, Thioflavin S, Congo red or anti-A4 antibodies Soc Neurosci Abst 18: 732
2. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiat Psych Gerichtl Med 64: 146-148 [Translation (1987): About a peculiar disease of the cerebral cortex. Alzheimer Dis Assoc Disord 1: 7-8]
3. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiat Psych Gerichtl Med 64: 146-148 [Translation (1987): About a peculiar disease of the cerebral cortex. Alzheimer Dis Assoc Disord 1: 7-8]
4. Barrow CJ, Zagorski MG (1991) Solution structures of β-peptide and its constituent fragments: Relation to amyloid deposition Science 253 179-182
5. Barrow CJ, Yasuda A, Kenny PTM, Zagorski MG (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease Analysis of circular dichroism spectra J Mol Biol 225: 1075-1093
6. Bladen HA, Nylen MU, Glenner GG (1966) The ultrastructure of human amyloid as revealed by the negative staining technique J Ultrastruct Res 14 449-459
7. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs J Biol Chem 267: 546-554
8. Castan̄o EM, Frangione B (1995) Non-Alzheimer's disease amyloidoses of the nervous system. Curr Opin Neurosci 8. 279-285
9. Cohen AS, Calkins E (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins Nature 183: 1202-1203
10. Cummings BJ, Cotman CW (1995) Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity Lancet 326: 1524-1528
11. Dyrks T, Dyrks E, Masters CL, Beyreuther K (1993) Amyloidogenicity of rodent and human βA4 sequences FEBS Lett 324: 231-236
12. Esler WP, Stimson SR, Ghilardi JR, Lu Y-A, Felix AM, Vinters HV, Lee JP, Mantyh PW, Maggio JE (1995) Aggregation and deposition of Aβ in Alzheimer's disease are distinct biochemical processes Soc Neurosci Abst 21 475
13. Esler WP, Stimson ER, Ghilardi JR, Vinters HV, Lee JP, Mantyh PW, Maggio JE (1996) In vitro growth of Alzheimer's disease β-amyloid plaques displays first-order kinetics Biochemistry 35. 749-757
14. Esler WP, Stimson ER, Jennings JM, Ghilardi JR, Mantyh PW, Maggio JE (1996) Zinc-induced aggregation of human and rat β-amyloid peptides in vitro. J Neurochem 66: 723-732
15. Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT Jr (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92: 763-767
16. Fabian H, Szendrei G.I, Mantsch HH, Greenberg BD, Otvos L Jr (1994) Synthetic post-translationally modified human Aβ peptide exhibits markedly increased tendency to form β-pleated sheets in vitro Eur J Biochem 221: 959-964
17. Fabian H, Szendrei GI, Mantsch HH, Otvos L Jr (1993) Comparative analysis of human and Dutch-1 type Alzheimer β-Amyloid peptides by infrared spectroscopy and circular dichroism. Biochem Biophys Res Comm 191. 232-239
18. Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J 60: 1190-1201
19. Fraser PE, Nguyen JT, Inouye H, Surewicz WT, Selkoe DJ, Podlisny MB, Kirschner DA (1992) Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein Biochemistry 31: 10716-10723
20. Fraser PE, Lévesque L, McLachlan, DR (1994) Alzheimer Aβ amyloid forms an inhibitory neuronal substrate. J Neurochem 62: 1227-1230
21. Fukuchi K, Sopher B, Martin GM (1993) Neurotoxicity of β-amyloid (letter, comment). Nature 361: 122-123
22. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, et al (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373: 523-527.
23. Glenner GG, Wong CW (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890
24. Glenner GG, Wong CW (1984) Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Comm 122: 1131-1135
25. Goldgaber D, Lerman JI, McBride OW, Saffioti U, Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235: 877-880
26. Gowing E, Roher AE, Woods AE, Cotter RJ, Chaney M, Little SP, Ball MJ (1994) Chemical characterization of Aβ(17-42) peptide, a component of diffuse amyloid depositis of Alzheimer's disease J Biol Chem 269: 10987-10990
27. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH, Suzuki N, Younkin SG (1995) Amyloid beta protein (A beta) in Alzheimer's disease brain Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43) J Biol Chem 270: 7013-7016
28. Greenberg BD (1995) The COOH-terminus of the Alzheimer's disease amyloid Aβ peptide: Differences in length influence the process of amyloid deposition in Alzheimer brain, and tell us something about the relationships among parenchymal and vessel-associated amyloid deposits. Amyloid 2: 195-203
29. Griffiths JM, Ashburn TT, Auger M, Costa PR, Griffin RG, Lansbury PT Jr (1995) Rotational resonance solid-state NMR elucidates a strutural model of panceatic amyloid. J Am Chem Soc 117. 3539-3546
30. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322-325
31. Halverson K, Fraser PE, Kirschner DA, Lansbury PT Jr (1990) Molecular determinants of amyloid deposition in Alzheimer's disease: Conformational studies of synthetic β-protein fragments. Biochemistry 29. 2639-2644
32. Halverson KH, Sucholeiki I, Ashburn TT, Lansbury PT Jr (1991) Location of β-sheet-forming sequences in amyloid proteins by FTIR. J Am Chem Soc 113. 6701-6703
33. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12: 383-388
34. Hawkins PN, Cavender JP, Pepys MB (1990) Evaluation of systemic amyloidosis by scintigraphy with 125-I labeleled serum amyloid P component. N Engl J Med 323: 508-513
35. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K (1991) Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J Mol Biol 218: 149-163
36. Hilbich C, Kisters-Woike B, Reed J, Masters CL, Beyreuther K (1992) Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptides. J Mol Biol 228: 460-473
37. Inouye H, Fraser PE, Kirschner DA (1993) Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: Analysis by X-ray diffraction. Biophys J 64. 502-519
38. Iwatsubo T, Okada A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an intially deposited species is Aβ42(43). Neuron 13: 45-53
39. Jacobson DR, Buxbaum JN (1991) Genetic aspects of amyloidosis. Adv Hum Genet 20. 69-123
40. Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 4693-4697
41. Jarrett JT, Costa PR, Griffin RG, Lansbury PT Jr (1993) Models of the βprotein C-terminus: Differences in amyloid structure may lead to segregation of "long" and "short" fibrils. J Am Chem Soc 116 9741-9742
42. Jarrett JT, Lansbury PT Jr (1993) Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73: 1055-1058
43. Kang J, Lemaire KH, Unterbeck A, Salbaum J, Masters CL, Grsechik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736
44. Kelly J (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 6: 11-17
45. Kelly J, Lansbury PT Jr (1994) A chemical approach to elucidate the mechanism of transthyretin and β-protein amyloid fibril formation Amyloid 1: 186-205
46. Kirschner DA, Abraham C, Selkoe DJ (1986) X-ray diffraction from intraneuronal paired helical filiments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-β conformation. Proc Natl Acad Sci USA 83: 503-507
47. Kirschner DA, Inoye H, Duffy LK, Sinclair A, Lind M, Selkoe, DJ (1987) Synthetic peptide homologous to β protein from Alzheimer's disease forms amyloid-like fibrils in vitro Proc Natl Acad Sci USA 84: 6953-6957
48. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genetics 9: 21-29
49. Lansbury PT Jr, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RGS, Tidor B, Griffin RG (1995) Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nature Struct Biol 2: 990-998
50. Lee JP, Stimson ER, Ghilardi JR, Mantyh PW, Lu Y-A, Felix AM, Maggio JE (1994) Conformational features of plaque-competent amyloid peptides. Soc Neurosci Abst 20: 606
51. 1H NMR of Aβ congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry 34: 5191-5200
52. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB (1996) On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants. Proc Nat Acad Sci USA 93: 1125-1129
53. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments Nature 372: 92-94
54. Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW (1992) Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89. 5462-5466
55. Mantyh PW, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR., Vinters HV, Labenski ME, Maggio JE (1991) Reversible in vitro growth of Alzheimer disease β-amyloid plaques. Bull Clin Neurosci 56: 73-85
56. Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE (1993) Aluminum, iron and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem 61: 1171-1174
57. Marsh RE, Corey RB, Pauling L (1955) An investigation of the structure of silk fibroin. Biochim Biophys Acta 16: 1-34
58. Mattson MP, Cheng B, Davis D, Bryant K, Leiberburg I, Rydel R (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12 376-389
59. Miller DL, Papayannapoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301: 41-52
60. Mon H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid β-protein in Alzheimer's disease. J Biol Chem 267: 17082-17086
61. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnsonwood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, et al (1995) Reduction of beta-amyloid peptide(42) in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol 38: 643-648
62. Otvos L, Szendrei G, Lee VM-Y, Mantsch HH (1993) Human and rodent Alzheimer β-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Eur J Biochem 211: 249-257
63. Pike CJ, Walencewicz J, Glabe CG, Cotman CW (1991) Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures. Eur J Pharmacol 207: 367-368
64. Pike CJ, Walencewicz J, Glabe C G, Cotman CW (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity Brain Res 563: 311-314
65. Pike CJ, Cummings BJ, Cotman CW (1992) β-amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology. NeuroReport 3: 769-772
66. Pike CJ, Burdick D, Walencewicz J, Glabe CG, Cotman CW (1993) Neurodegeneration induced by β-amyloid peptides in vitro. The role of peptide assembly state. J Neurosci 13: 1676-1687
67. Pike CJ, Overman MJ, Cotman CW (1995) Amino-terminal deletions enhance aggregation of β-amyloid peptides in vitro. J Biol Chem 270: 23895-23898
68. Pike CJ, Walencewicz-Wasserman J, Kosmoski D, Cribbs H, Glabe CG, Cotman CW (1995) Structure-activity analyses of β-amyloid peptides: Contributions of the β25-35 region to aggregation and neurotoxicity. J Neurochem 64: 253-265
69. Roher AE, Ball MJ, Bhave SV, Wakade AR (1991) β-Amyloid form Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. Biochem Biophys Res Commun 174: 572-579
70. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Coffer RI, Reardon IM, Zurcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD (1993) Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 268: 3072-3083
71. Roher AE, Lowenson JD, Clarke S, Woods AS, Coner RJ, Gowing E, Ball MJ (1993) β-Amyloid (1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer's disease. Proc Natl Acad Sci USA 90. 10836-10840
72. Roses AD (1996) From genes to mechanism to therapies. Lessons to be learned from neurological disorders Nature Medicine 2: 267-269
73. N3(PE), in senile plaques. Neuron 14. 456-466
74. Schellenberg GD (1995) Genetic dissection of Alzheimer's disease, a heterogenous disorder. Proc Nat Acad Sci USA 92: 8552-8559
75. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6 487-498
76. Selkoe DJ (1994) Alzheimer's disease: A central role for amyloid. J Neuropathol Exp Neurol 53 438-447
77. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids Nature 359. 325-327
78. Shen CL, Fitzgerald MC, Murphy RM (1994) Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide. Biophys J 67. 1238-46
79. Shen CL, Murphy RM (1995) Solvent effects on self-assembly of beta-amyloid peptide Biophys J 69: 640-51
80. Shen CL, Scott GL, Merchant F, Murphy RM (1993) Light scattering analysis of fibril growth from the amino-terminal fragment beta(1-28) of beta-amyloid peptide. Biophys J 65: 2383-95
81. Summons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN et al. (1994) Secondary structure of amyloid β-peptide correlates with neurotoxic activity in vitro Mol Pharmacol 45: 373-379
82. Sipe JD (1992) Amyloidosis Annu Rev Biochem 61: 947-75
83. Soreghan B, Kosmoski J, Glabe C (1994) Surfactant properties of Alzheimer's Aβ peptides and mechanism of amyloid aggregation J Biol Chem 269. 28551-28554
84. Sorimachi K, Craik DJ (1994) Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis Eur J Biochem 219: 237-251
85. Soto C, Castan̄o EM, Frangione B, Inestrosa NC (1995) The alpha-helical to beta-strand transition in the aminoterminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem 270: 3063-3067
86. Soto C, Castalo EM, Kumar RA, Beavis RC, Frangione B (1995) Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure Neurosci Lett 200. 105-108
87. Soto C, Frangione B (1995) Two conformational states of amyloid beta-peptide. Implications for the pathogenesis of Alzheimers disease. Neurosci Lett 186: 115-118
88. Sticht H, Bayer P, Willbold D, Dames S, Hilbich C, Beyreuther K, Frank RW, Rösch P (1995) Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur J Biochem 233: 293-298
89. 717) mutants. Science 264: 1336-1340
90. Talafous J, Marcinowski KJ, Klopman G, Zagorski MG (1994) Solution structure of residues 1-28 of the amyloid β-peptide. Biochemistry 33: 7788-7796
91. Tamaoka A, Kondo T, Odaka A, Sahara N, Sawamura N, Ozawa K, Suzuki N, Shoji S, Mori H (1994) Biochemical evidence for the long-tail form (Aβ1-42/43) of amyloid β protein as a seed molecule in cerebral deposits os Alzheimer's disease. Biochem Biophys Res Commun 205. 834-842
92. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff LL, Gusella JF, Neve RL (1987) Protease inhibitor domain encoded by an amyloid precursor protein mRNA associated with Alzheimer's disease Nature 331: 528-530
93. 23 residue affects the aggregation properties of Alzheimer amyloid β protein analogues. J Biol Chem 269: 10205-10208
94. Tomski SJ, Murphy RM (1992) Kinetics of aggregation of synthetic beta-amyloid peptide. Arch Biochem Biophys 294. 630-638
95. van Gool WA, Kuiper MA, Walstra GJM, Wolters ECh, Bolhuis PA (1994) Concentrations of amyloid β-protein in cerebrospinal fluid of patients with Alzheimer's disease Ann Neurol 37: 277-279
96. Walker LC, Ghilardi JR, Rogers S, Catton M, Maggio JE, Mantyh PW (1995) In vivo binding of synthetic β-amyloid (Aβ) to endogenous Aβ in aged monkeys. Soc Neurosci Abst 21: 257
97. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of β-protein. Reversal by tachykinin neuropeptides. Science 250: 279-282
98. Younkin SG (1995) Evidence that Aβ-42 is the real culprit in Alzheimer's disease. Ann Neurol 37: 287-288
99. Zagorski MG, Barrow CJ (1992) NMR studies of amyloid β-peptides. Proton assignments, secondary structure, and mechanism of an α-helix to β-sheet conversion for a homologous, 28-residue, N-terminal fragment Biochemistry 31: 5621-5631
100. Zhang H, Kaneko K, Nguyen JT, Livshits TL, Baldwin MA, Cohen FE, James TL, Prusiner SB (1995) Conformational transitions in peptides containing two putative α-helices of the prion protein. J Mol Biol 250: 514-526